Ekologija 56, 2633 (2010)
The article says these show how much metabolic dysfunction is present, which providers weigh when personalizing treatment alongside the trial evidence
Some patients report a phase of increased general sweating (not just at night) during the most active weight-loss months, which usually resolves once the body adapts
For instance, the FDA's approval of GLP-1 agonists for both type 2 diabetes and obesity has prompted professional organizations to update their clinical guidelines, outlining specific recommendations for their use in various patient populations
On metabolic stress, ASCT2 ( SLC1A5 ), LAT1 ( SLC7A5 ), CAT1 ( SLC7A1 ), GLYT1 ( SLC6A9 ), and xCT, the light chain subunit of system (SLC7A11), are elevated by ATF4 activation, which facilitates the uptake of glutamine, leucine, arginine, lysine, glycine, and cystine (Lopez et al., 2007
Both contain semaglutide and work the same way